Additionally, hepatitis B or C infections, as well as serum concentrations of tumor markers—namely alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II)—should be taken into account when assessing prognostic factors. This evidence concerns the gene AFP and hepatitis B virus infection.